Advertisement

Topics

Nightstar Brings Tuyen Ong On Board as Chief Development Officer

11:44 EDT 4 Aug 2017 | Xconomy

Tuyen Ong is joining Nightstar as executive vice president and chief development officer. Ong comes to Nightstar from South Plainfield, NJ-based PTC Therapeutics (NASDAQ: PTCT), where we was chief medical officer. Ong will be based in Lexington, MA, where London-based Nightstar has its U.S. headquarters. The company, which develops treatments for rare congenital retinal diseases, […]

Original Article: Nightstar Brings Tuyen Ong On Board as Chief Development Officer

NEXT ARTICLE

More From BioPortfolio on "Nightstar Brings Tuyen Ong On Board as Chief Development Officer"

Quick Search
Advertisement
 

Relevant Topic

Congenital Diseases
Congenital conditions are those which are present from birth. They include structural deformities or loss of function in organs such as the <!--LGfEGNT2Lhm-->heart, gut or skeletal system. They can be corrected by <!--LGfEGNT2Lhm-->surgery, m...